Bausch Health
BHC
#4798
Rank
$2.04 B
Marketcap
$5.47
Share price
0.37%
Change (1 day)
21.56%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -$3.24

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.24. In 2025 the company made an earnings per share (EPS) of $0.42 an increase over its 2024 EPS that were of -$0.12.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$3.24-871.43%
2025$0.42-450%
2024-$0.12-92.59%
2023-$1.62160.89%
2022-$0.62-76.64%
2021-$2.6668.45%
2020-$1.58-68.91%
2019-$5.07-57.11%
2018-$11.83-272.22%
2017$6.87-199.29%
2016-$6.92798.7%
2015-$0.77-128.31%
2014$2.72-204.62%
2013-$2.60602.7%
2012-$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-$0.24-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$0.95-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA